醫渡科技(02158.HK)與清華大學啟動智慧醫療產業發展相關基礎研究
醫渡科技(02158.HK)公布,清華大學與公司於4月11日再度啟動重要基礎研究課題,以期解決智慧醫療產業發展過程中基礎設施建設面臨的難點問題。當日來自清華大學和醫渡雲的相關技術負責人簽署並啟動三項課題合作,即「聯邦學習和安全計算性能優化研究」、「基於區塊鏈的醫療數據存證溯源共享機制研究」和「基於Agent的疫情傳播仿真平台及政策研究」,以加快關鍵核心技術攻關,助力智慧醫療基礎設施建設,加速研究成果轉化與落地,促進醫療產業轉型升級。(ek/u)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.